Tariffs and FDA staffing gaps are quietly reshaping clinical trial supply chains. From comparators to customs delays, these forces are creating real risk for timelines, budgets, and patients.
- Why Clinical Supply Risk Starts With Demand Signals
- Clinical Supply Planning In A More Volatile And Regionalized World
- Navigating Brazil's Medical Device Clinical Trial Import Process
- Where Clinical Supply Chain Meets Humanity: Why It's Never "Just A Box"
- Managing Supply Chain Risk In Scale-Up And Multisite Trials
- Global Clinical Supply — Confronting Persistent Challenges With Strategic Action
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Building A Culture Of Compliance In Clinical Supply
ON-DEMAND WEBINARS
Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.
Explore the opportunities to optimize your supply chain strategy and facilitate direct-to-site, direct-to-patient and hybrid services utilizing a global GMP depot network.
Join patient-centric supply chain expert Marco Hogenboom for a discussion on how to accelerate the delivery of advanced therapies in an unpredictable environment through supply chain customization from clinical to commercialization.
Join Neta Bendelac from 4G Clinical and Limor Teomim from IMP CSS for an informative webinar as they explore how to mitigate the growing challenges faced as a result of the pandemic when it comes to DtP strategies and virtual trial design.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1296498102 lab technician]( "Clinical Supply Optimization: Process Improvement Accelerates Trials")
Clinical Supply Optimization: Process Improvement Accelerates TrialsA biopharmaceutical sponsor required the study start-up phase to be reduced to 91 days, involving comparator sourcing and blinding, kitting, packaging, labeling, and distribution to the sites.
-
![iStock-1224887299-box-logistics-package]( "The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective")
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply PerspectivePerhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
![GettyImages-1344606074 data insights]( "Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics")
Data-Driven Adaptive Trials Enhance Safety, Progress, And EconomicsBy offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
![GettyImages-2170642314-year 2025]( "What Does 2025 Hold For Pharma?")
What Does 2025 Hold For Pharma?Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
![GettyImages-517118579 patient]( "Delivering Lifesaving Intravenous Therapy Across The USA Within 24 Hours")
Delivering Lifesaving Intravenous Therapy Across The USA Within 24 HoursThe goal was to successfully deliver time-critical intravenous therapy, Legalon, from a GMP Philadelphia depot to sites across the USA to treat patients suffering from amatoxin poisoning.
-
![Laptop clinical trials iStock-653839742]( "What Are Decentralized Clinical Trials (DCTs)?")
What Are Decentralized Clinical Trials (DCTs)?Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
![GettyImages-1316775813-vial-production]( "Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C")
Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°CThis study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.
-
![GettyImages-1305685152 vaccine]( "eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks")
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 WeeksExamine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
![iStock-1288879010-gloves-mask-box]( "5 Common Clinical Supply Chain Speedbumps")
5 Common Clinical Supply Chain SpeedbumpsClinical trials can be very complex. Discover the need to connect planning and oversight from sourcing to shipping, along with mastering requirements such as cold chain, border slowdowns, and data privacy.
-
![GettyImages-2036497698 clinical lab]( "Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology")
Solutions For Sponsors Utilizing Drafted Guidance For PROs In OncologyExplore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
